デフォルト表紙
市場調査レポート
商品コード
1726307

マッピングカテーテルの世界市場:市場規模・シェア・動向分析 (技術別・適応症別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)

Mapping Catheters Market Size, Share & Trends Analysis Report By Technology (High-Density (HD) Mapping, Contact Force Sensing), By Indication (AF, AFL, VT), By End Use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 90 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
マッピングカテーテルの世界市場:市場規模・シェア・動向分析 (技術別・適応症別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)
出版日: 2025年04月15日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

マッピングカテーテル市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のマッピングカテーテルの市場規模は2025年から2030年にかけてCAGR 8.9%を記録し、2030年には49億6,000万米ドルに達する見込みです。

市場を牽引する主な要因は、CVD症例の増加、不整脈(AF)発生率の増加、技術進歩、政府の取り組みです。2023年8月に発表された(HRS)Heart Rhythm Societyの論文によると、心房細動(AFib)は、米国の600万人を含む全世界で約4,000万人が罹患しており、最も蔓延している心臓不整脈です。40歳以上の成人のほぼ4人に1人が心房細動を発症するリスクに直面しているが、多くの場合、初期症状に気づかないままです。このようなニーズの高まりが市場を活性化させています。なぜなら、これらのツールは不整脈部位をピンポイントで特定し、的を絞った治療を導き、最終的に患者の予後を改善し、脳卒中や心不全のような重篤な合併症のリスクを低減するために不可欠だからです。

マッピングシステムの技術進歩が市場成長の原動力となっています。例えば、2024年6月には、多電極バスケットカテーテルや心臓動脈や心外膜静脈のマッピングが可能なデバイスのような新しいツールにより、真空治療中であっても心臓の活性化シーケンスの詳細な3次元可視化が可能になります。さらに、コンピュータ化された非接触マッピングシステムは、心内膜表面に直接触れることなく、電位図を再構成し、3Dアイソポテンシャルマップを作成するアルゴリズムを活用することにより、電気生理学に変革をもたらします。このような技術的進歩を補完するのが、遠隔モニタリングと感染制御の改善であり、これにより病院環境外での継続的な心拍評価が可能になり、患者の安全性が向上し、タイムリーな治療介入が可能になり、侵襲的処置に伴うリスクが最小化されます。

さらに、市場参入企業による戦略的イニシアチブの高まりが市場の成長を後押ししています。例えば、2024年5月、ジョンソン・エンド・ジョンソンのメドテック企業であり、心臓不整脈治療の世界的リーダーであるバイオセンス・ウェブスターは、3D心臓マッピング・プラットフォームの高度な反復であるCARTO 3システム・バージョン8を発表しました。このアップグレードは、心房細動などの不整脈に対するカテーテルアブレーション治療の精度と手技効率を高めるものです。最新の追加機能の中には、CARTO ELEVATE(TM)およびCARTOSOUND(TM)FAMモジュールがあり、いずれも複雑なアブレーション手技における精度、一貫性、ワークフローの改善で電気生理学者をサポートするために開発されました。

マッピングカテーテル市場:分析概要

  • 高密度(HD)マッピングのセグメントが、2024年に49.3%以上の最大シェアを占めました。心房細動の罹患率の増加と技術の進歩がこのセグメントの成長を牽引しています。高密度(HD)マッピングは、正確な不整脈診断と治療のために心臓から詳細な電気信号をキャプチャする技術です。
  • 心房細動(AF)セグメントは、心房細動の発生率の増加、主要企業によるイニシアチブの拡大、技術の進歩により、2024年には66.8%超の最大シェアを占めました。
  • 病院セグメントは、2024年に36.8%で最大のシェアを占めました。高度な電気生理学的介入に対する需要の高まりを反映して、病院ではカテーテル手技の実施が増加しています。
  • 北米は、2024年に40.4%のシェアを占め、市場を独占しました。これは、心臓手術の増加や技術の進歩など、心臓不整脈の有病率の増加によるものです。
  • 同市場には、アボット・ラボラトリーズ、アキュタス・メディカル、ジョンソン・エンド・ジョンソン、メドトロニック、ボストン・サイエンティフィック・コーポレーション、マイクロポート・サイエンティフィック・コーポレーション、レプ・メディカル、ステレオタクシス、Koninklijke Philips N.V.などの企業が参入しています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 マッピングカテーテル市場:変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • マッピングカテーテル市場:分析ツール
    • 業界分析:ポーターのファイブフォース分析
    • PESTEL分析

第4章 マッピングカテーテル市場:技術別の推定・動向分析

  • マッピングカテーテル市場:技術別ダッシュボード
  • マッピングカテーテル市場:技術別の変動分析
  • マッピングカテーテル市場:市場規模の予測と動向分析:技術別(2018~2030年)
  • 高密度(HD)マッピング
  • 接触力センシング
  • その他

第5章 マッピングカテーテル市場:適応症別の推定・動向分析

  • マッピングカテーテル市場:適応症別ダッシュボード
  • マッピングカテーテル市場:適応症別の変動分析
  • マッピングカテーテル市場:市場規模の予測と動向分析:適応症別(2018~2030年)
  • 心房細動(AF)
  • 心房粗動(AFL)
  • 心室頻拍(VT)
  • その他

第6章 マッピングカテーテル市場:最終用途別の推定・動向分析

  • マッピングカテーテル市場:最終用途別ダッシュボード
  • マッピングカテーテル市場:最終用途別の変動分析
  • マッピングカテーテル市場:市場規模の予測と動向分析:最終用途別(2018~2030年)
  • 病院
  • 外来手術センター
  • その他

第7章 マッピングカテーテル市場:地域別の推定・動向分析(国別・適応症別・適応症別・最終用途別)

  • 世界のマッピングカテーテル市場:地域別ダッシュボード
  • 市場規模の予測と動向分析(2018~2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 最近の動向と影響分析:主要メーカー別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要な流通業者・チャネルパートナーの一覧
    • 主要顧客
    • 主要企業の市場シェア分析 (2024年)
    • Abbott Laboratories
    • Acutus Medical, Inc.
    • Johnson &Johnson
    • Medtronic
    • Boston Scientific Corporation
    • Microport Scientific Corporation
    • Lepu Medical
    • Stereotaxis, Inc.
    • Koninklijke Philips NV
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Global mapping catheters market, by technology 2018 - 2030 (USD Million)
  • Table 4. Global mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 5. Global mapping catheters market, by end use, 2018 - 2030
  • Table 6. Global mapping catheters market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 8. North America mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 9. North America mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 10. North America mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 11. U.S. mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 12. U.S. mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 13. U.S. mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 14. Canada mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 15. Canada mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 16. Canada mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Mexico mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 18. Mexico mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 19. Mexico mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 20. Europe mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 21. Europe mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 22. Europe mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 23. Europe mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 24. UK mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 25. UK mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 26. UK mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Germany mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 28. Germany mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 29. Germany mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 30. France mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 31. France mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 32. France mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 34. Italy mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 35. Italy mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Spain mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 37. Spain mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 38. Spain mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 39. Denmark mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 40. Denmark mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 41. Denmark mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 42. Sweden mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Sweden mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 44. Sweden mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Norway mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 46. Norway mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 47. Norway mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Asia Pacific mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 52. Japan mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 53. Japan mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 54. Japan mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 55. China mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 56. China mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 57. China mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 58. India mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 59. India mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 60. India mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 61. Australia mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 62. Australia mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 63. Australia mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 64. Australia mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 65. Thailand mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 66. Thailand mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 67. Thailand mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 68. South Korea mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 69. South Korea mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 70. South Korea mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 71. Latin America mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 72. Latin America mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 73. Latin America mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 74. Latin America mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 75. Brazil mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 76. Brazil mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 77. Brazil mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 78. Argentina mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 79. Argentina mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 80. Argentina mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 81. MEA mapping catheters market, by country, 2018 - 2030 (USD Million)
  • Table 82. MEA mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 83. MEA mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 84. MEA mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 85. South Africa mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 86. South Africa mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 87. South Africa mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 89. Saudi Arabia mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 90. Saudi Arabia mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 91. UAE mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 92. UAE mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 93. UAE mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 94. Kuwait mapping catheters market, by technology, 2018 - 2030 (USD Million)
  • Table 95. Kuwait mapping catheters market, by indication, 2018 - 2030 (USD Million)
  • Table 96. Kuwait mapping catheters market, by end use, 2018 - 2030 (USD Million)
  • Table 97. Participant's overview
  • Table 98. Financial performance
  • Table 99. Key companies undergoing expansions
  • Table 100. Key companies undergoing acquisitions
  • Table 101. Key companies undergoing collaborations
  • Table 102. Key companies launching new products
  • Table 103. Key companies undergoing partnerships
  • Table 104. Key companies undertaking other strategies

List of Figures

  • Fig. 1 Mapping catheters market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Mapping catheters market revenues, 2023, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 Mapping catheters market Technology outlook:
  • Fig. 14 Mapping catheters market: Technology movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Global high-density (HD) mapping market, 2018 - 2030 (USD Million)
  • Fig. 17 Global contact force sensing market, 2018 - 2030 (USD Million)
  • Fig. 18 Global others market, 2018 - 2030 (USD Million)
  • Fig. 19 Mapping catheters market indication outlook:
  • Fig. 20 Mapping catheters market: indication movement analysis
  • Fig. 21 Global atrial fibrillation (AF) market, 2018 - 2030 (USD Million)
  • Fig. 22 Global tachycardia market, 2018 - 2030 (USD Million)
  • Fig. 23 Global atrial fibrillation market, 2018 - 2030 (USD Million)
  • Fig. 24 Global atrial flutter market, 2018 - 2030 (USD Million)
  • Fig. 25 Global ventricular tachycardia market, 2018 - 2030 (USD Million)
  • Fig. 26 Global others market, 2018 - 2030 (USD Million)
  • Fig. 27 Mapping catheters market end use outlook:
  • Fig. 28 Mapping catheters market: end use movement analysis
  • Fig. 29 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 30 Global ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 31 Global others market, 2018 - 2030 (USD Million)
  • Fig. 32 Regional market place: Key takeaways
  • Fig. 33 North America mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 36 Mexico mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 37 Europe mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 39 UK mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 40 France mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 41 Italy mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 42 Spain mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 44 Japan mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 45 China mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 46 India mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 50 MEA mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia mapping catheters market, 2018 - 2030 (USD Million)
  • Fig. 53 Market Participant Categorization
  • Fig. 54 Strategy mapping
目次
Product Code: GVR-4-68040-551-3

Mapping Catheters Market Growth & Trends:

The global mapping catheters market size is expected to reach USD 4.96 billion by 2030, registering a CAGR of 8.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market are the rising cases of CVD, increasing arrhythmia (AF) incidence, technological advancements, and government initiatives. According to the (HRS) Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib) affects nearly 40 million individuals globally, including 6 million in the United States, making it the most prevalent cardiac arrhythmia. Almost one in four adults over 40 face the risk of developing AFib, often without recognizing early symptoms; the demand for timely and accurate diagnosis is skyrocketing. This rising need fuels the market, as these tools are essential for pinpointing arrhythmic sites and guiding targeted treatment, ultimately improving patient outcomes and reducing the risk of serious complications like stroke and heart failure.

Technological advancements in mapping systems are driving market growth. For instance, in June 2024, New tools like multielectrode basket catheters and devices capable of mapping cardiac arteries and epicardial veins enable detailed three-dimensional visualization of cardiac activation sequences, even during vacuum therapy. Additionally, computerized non-contact mapping systems transform electrophysiology by leveraging algorithms to reconstruct electrograms and create 3D isopotential maps without direct contact with the endocardial surface. These technological strides are complemented by remote monitoring and infection control improvements, which allow continuous heart rhythm assessment outside of hospital environments-enhancing patient safety, enabling timely therapeutic interventions, and minimizing risks associated with invasive procedures.

Moreover, the rising strategic initiatives by the market players fuel market growth. For instance, in May 2024, Biosense Webster, a Johnson & Johnson MedTech company and a global leader in treating cardiac arrhythmias, introduced CARTO 3 System Version 8, an advanced iteration of its 3D cardiac mapping platform. This upgrade enhances precision and procedural efficiency during catheter ablation treatments for arrhythmias like atrial fibrillation. Among the latest additions are the CARTO ELEVATE(TM) and CARTOSOUND(TM) FAM Modules, both developed to support electrophysiologists with improved accuracy, consistency, and workflow during complex ablation procedures.

Mapping Catheters Market Report Highlights:

  • The High-Density (HD) mapping segment held the largest share of over 49.3% in 2024. The increasing incidence of AF and technological advancement drives the segment growth. High-Density (HD) Mapping is a technique that captures detailed electrical signals from the heart for precise arrhythmia diagnosis and treatment
  • The Atrial Fibrillation (AF) segment held the largest share, over 66.8%, in 2024 due to the increasing incidence of AF, growing initiatives by key players, and technological advancements
  • The hospital segment held the largest share at 36.8% in 2024. Hospitals increasingly perform catheter procedures, reflecting the growing demand for advanced electrophysiological interventions
  • North America dominated the market, with a share of 40.4% in 2024, owing to the increasing prevalence of cardiac arrhythmia, including increasing cardiac procedures and technological advancements
  • Market players operating in the market include Abbott Laboratories, Acutus Medical, Inc., Johnson & Johnson, Medtronic, Boston Scientific Corporation, Microport Scientific Corporation, Lepu Medical, Stereotaxis, Inc., and Koninklijke Philips N.V.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Indication
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology Segment
    • 2.2.2. Indication Segment
    • 2.2.3. End-use Segment
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Mapping Catheters Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiac arrhythmias
      • 3.2.1.2. Increased cardiac procedures
      • 3.2.1.3. Technological advancements
      • 3.2.1.4. Growing awareness of early detection of AF
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost associated with the devices and procedures
      • 3.2.2.2. Regulatory compliance
  • 3.3. Mapping Catheters Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Mapping Catheters Market: Technology Estimates & Trend Analysis

  • 4.1. Mapping Catheters Market: Technology Dashboard
  • 4.2. Mapping Catheters Market: Technology Movement Analysis
  • 4.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Technology, 2018 - 2030 (USD Million)
  • 4.4. High-Density (HD) Mapping
    • 4.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Contact Force Sensing
    • 4.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Mapping Catheters Market: Indication Estimates & Trend Analysis

  • 5.1. Mapping Catheters Market: Indication Dashboard
  • 5.2. Mapping Catheters Market: Indication Movement Analysis
  • 5.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by Indication, 2018 - 2030 (USD Million)
  • 5.4. Atrial Fibrillation (AF)
    • 5.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.5. Atrial Flutter (AFL)
    • 5.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.6. Ventricular Tachycardia (VT)
    • 5.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Mapping Catheters Market: End-use Estimates & Trend Analysis

  • 6.1. Mapping Catheters Market: End-use Dashboard
  • 6.2. Mapping Catheters Market: End-use Movement Analysis
  • 6.3. Mapping Catheters Market Size & Forecasts and Trend Analysis, by End-use, 2018 - 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Mapping Catheters Market: Regional Estimates & Trend Analysis by Country, Technology, Indication, & End-use

  • 7.1. Global Mapping Catheters Market: Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2018 - 2030
  • 7.3. North America
    • 7.3.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key country dynamics
      • 7.3.4.2. Regulatory framework/ reimbursement structure
      • 7.3.4.3. Competitive scenario
      • 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.9. Denmark
      • 7.4.9.1. Key country dynamics
      • 7.4.9.2. Regulatory framework/ reimbursement structure
      • 7.4.9.3. Competitive scenario
      • 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Japan
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework/ reimbursement structure
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. Market Estimates and Forecasts 2018 - 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. South Africa
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Abbott Laboratories
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Acutus Medical, Inc.
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Johnson & Johnson
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Medtronic
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Boston Scientific Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Microport Scientific Corporation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Lepu Medical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Stereotaxis, Inc.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Koninklijke Philips N.V.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives